dextromethorphan hydrobromide and promethazine hydrochloride syrup
proficient rx lp - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.
bisolvon dry
pharmacy retailing (nz) ltd t/a healthcare logistics - dextromethorphan hydrobromide monohydrate 10.5mg - pastille - 10.5 mg - active: dextromethorphan hydrobromide monohydrate 10.5mg excipient: acacia betadex citric acid limette flavour 18635/02 honey flavour 8366/001 levomenthol light liquid paraffin maltitol purified water quinoline yellow saccharin sodium sodium cyclamate white beeswax - bisolvon dry pastilles are used for the symptomatic treatment of dry, irritant, unproductive coughs.
dextromethorphan hydrobromide and promethazine hydrochloride syrup
atlantic biologicals corp. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see ). precautions, drug interactions promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.
dextromethorphan hbr and guaifenesin solution
akorn - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - dextromethorphan hydrobromide 10 mg in 5 ml - cough suppressant expectorant
dextromethorphan hbr 15 mg- dextromethorphan hbr capsule, liquid filled
humanwell puracap pharmaceuticals (wuhan) co., ltd. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - dextromethorphan hydrobromide 15 mg - cough suppressant temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
dextromethorphan polistirex extended release- dextromethorphan polistirex suspension
padagis israel pharmaceuticals ltd - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - dextromethorphan hydrobromide 30 mg in 5 ml - cough suppressant temporarily relieves
promethazine hydrochloride and dextromethorphan hydrobromide syrup
rebel distributors corp - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.
dextromethorphan hydrobromide capsule, liquid filled
spirit pharmaceuticals,llc - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - dextromethorphan hydrobromide 15 mg - cough suppressant relieves cough due to minor throat and bronchial irritation may occur with a cold
dextromethorphan hydrobromide capsule, liquid filled
j.p. business enterprise - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - dextromethorphan hydrobromide 15 mg - cough suppressant temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.
promethazine hydrochloride and dextromethorphan hydrobromide syrup
morton grove pharmaceuticals, inc. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.